These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 116429)

  • 61. [Viewpoint on the Federal Medical Board's "Guidelines for blood group determination and blood transfusion" of 1 February 1979].
    Rügheimer E; Hutschenreuter K
    Prakt Anaesth; 1979 Aug; 14(4):361-2. PubMed ID: 493235
    [No Abstract]   [Full Text] [Related]  

  • 62. Transfusion for a patient of cis-AB blood type undergoing a redo cardiac operation.
    Yoon SZ; Lee HM; Kim HS; Kim SD; Oh AY; Kim CS
    Br J Anaesth; 2005 Jun; 94(6):733-4. PubMed ID: 15749736
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Quality control and transfusion reactions.
    Beal RW
    Anaesth Intensive Care; 1980 May; 8(2):172-7. PubMed ID: 6772054
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The computer or electronic crossmatch.
    Butch SH; Oberman HA
    Transfus Med Rev; 1997 Oct; 11(4):256-64. PubMed ID: 9345707
    [No Abstract]   [Full Text] [Related]  

  • 65. Application of DNA analysis to the quality assurance of reagent red blood cells.
    Storry JR; Olsson ML; Reid ME
    Transfusion; 2007 Jul; 47(1 Suppl):73S-8S. PubMed ID: 17593291
    [No Abstract]   [Full Text] [Related]  

  • 66. The UK National External Quality Assessment Scheme in Blood Group Serology. ABO and D grouping and antibody screening 1982-1983.
    Holburn AM; Prior D
    Clin Lab Haematol; 1986; 8(3):243-56. PubMed ID: 3093139
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [New formulations in the guidelines and their importance for anesthesiologists].
    Götz E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Oct; 33(10):666-9. PubMed ID: 9825054
    [No Abstract]   [Full Text] [Related]  

  • 68. Type and hold system for better blood utilization.
    Huang ST; Lair J; Floyd DM; Cole GW
    Transfusion; 1980; 20(6):725-8. PubMed ID: 6776668
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The major factors and weak links that must be considered to achieve safety in compatability testing.
    Voak D; Knowles SM; Milkins CE; Chapman JS; Scott M
    Vox Sang; 2002 Aug; 83 Suppl 1():327-32. PubMed ID: 12617163
    [No Abstract]   [Full Text] [Related]  

  • 70. Reviewing the basics: blood group compatibility.
    Nursing; 2000 Dec; 30(12):24. PubMed ID: 11249428
    [No Abstract]   [Full Text] [Related]  

  • 71. [The French reference laboratory for rare blood groups: activities in 2001].
    Rouger P; Noizat-Pirenne F; Ansart-Pirenne H; Le Pennec PY
    Transfus Clin Biol; 2003 Feb; 10(1):41-6. PubMed ID: 12668187
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [The blood transfusion, a story of donations].
    Romanacce I
    Rev Infirm; 2012 Jan; (177):16-7. PubMed ID: 22372104
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Effect of various plasma substitutes on blood groups].
    Kox W; Höwekamp C
    Infusionsther Klin Ernahr; 1979 Dec; 6(6):341-4. PubMed ID: 94317
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Proficiency testing in immunohaematology in Ontario, Canada, and in the United Kingdom: a comparative study.
    Pinkerton PH; Zuber ED; Wood DE; Holburn AM; Prior D
    J Clin Pathol; 1985 May; 38(5):570-4. PubMed ID: 3923059
    [TBL] [Abstract][Full Text] [Related]  

  • 75. False positive reactions with chemically modified anti-D.
    Sinclair M; Jones EC; Unrau L
    Transfusion; 1989; 29(6):559-60. PubMed ID: 2501917
    [No Abstract]   [Full Text] [Related]  

  • 76. False-positive results with chemically modified anti-D do not indicate a need to use a separate, immunologically inert Rh control reagent.
    Judd WJ; Steiner EA; Oberman HA; Giacherio D
    Transfusion; 1988; 28(4):339-41. PubMed ID: 3133845
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A computer-based record system for a hospital transfusion service.
    Eggert AA; Traver MI; Blankenheim TJ
    Transfusion; 1980; 20(1):55-65. PubMed ID: 6766583
    [TBL] [Abstract][Full Text] [Related]  

  • 78. False-positive results with chemically modified anti-D.
    Jones EC; Sinclair M; Unrau L; Growe G
    Transfusion; 1987; 27(2):142-4. PubMed ID: 3103268
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Indigenous development of antibody screening cell panels at Armed Forces Institute of Transfusion (AFIT).
    Salamat N; Bhatti FA; Yaqub M; Hafeez M; Hussain A; Ziaullah
    J Pak Med Assoc; 2005 Oct; 55(10):439-43. PubMed ID: 16304853
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Commercially obtained AB serum causing unacceptably high ionic strength in LISS techniques.
    Fisher BJ
    Transfusion; 1988; 28(2):198. PubMed ID: 3354051
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.